WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹409 Cr | ₹334 Cr | ₹-315 Cr | ₹-71 Cr | ₹-1,171 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹409 Cr |
| Mar2024 | ₹334 Cr |
| Mar2023 | ₹-315 Cr |
| Mar2022 | ₹-71 Cr |
| Mar2021 | ₹-1,171 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹409 Cr | 22.46 | |
| Mar2024 | ₹334 Cr | Positive | |
| Mar2023 | ₹-315 Cr | Negative | |
| Mar2022 | ₹-71 Cr | Negative | |
| Mar2021 | ₹-1,171 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,130.1 Cr | -1.4% | -7.6% | 18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -1.4% |
-7.6% |
18.3% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses